Impact of CardiolRx on Myocardial Recovery in Acute Myocarditis. A Double-blind, Placebo-controlled Trial
Latest Information Update: 17 Jul 2024
At a glance
- Drugs Cannabidiol (Primary)
- Indications Myocarditis
- Focus Therapeutic Use
- Acronyms ARCHER
- Sponsors Cardiol Therapeutics
- 10 Mar 2023 Planned End Date changed from 1 Jun 2025 to 1 Dec 2024.
- 10 Mar 2023 Planned primary completion date changed from 1 Dec 2024 to 1 Nov 2024.
- 22 Aug 2022 Status changed from active, no longer recruiting to recruiting.